BlackRock’s Lineage Cell Therapeutics LCTX Stock Holding History

BlackRock’s Portfolio LCTX Stock Details LCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.11M	Buy	3,864,757 +30,644	+0.8%	+$51.7K	﹤0.01%	3749
2025 Q4	$6.4M	Buy	3,834,113 +1,603,357	+72%	+$2.78M	﹤0.01%	3728
2025 Q3	$3.77M	Sell	2,230,756 -29,992	-1%	-$35.5K	﹤0.01%	3899
2025 Q2	$2.05M	Sell	2,260,748 -9,192,557	-80%	-$5.45M	﹤0.01%	4051
2025 Q1	$5.17M	Buy	11,453,305 +1,358,628	+13%	+$797K	﹤0.01%	3635
2024 Q4	$5.07M	Buy	10,094,677 +174,877	+2%	+$128K	﹤0.01%	3729
2024 Q3	$8.98M	Buy	9,919,800 +360,334	+4%	+$334K	﹤0.01%	3464
2024 Q2	$9.53M	Buy	9,559,466 +1,065,071	+13%	+$1.18M	﹤0.01%	3410
2024 Q1	$12.6M	Sell	8,494,395 -37,103	-0.4%	-$42.1K	﹤0.01%	3234
2023 Q4	$9.3M	Sell	8,531,498 -756,536	-8%	-$829K	﹤0.01%	3433
2023 Q3	$11M	Buy	9,288,034 +275,970	+3%	+$375K	﹤0.01%	3275
2023 Q2	$12.7M	Buy	9,012,064 +5,302,486	+143%	+$7.33M	﹤0.01%	3300
2023 Q1	$5.56M	Sell	3,709,578 -74,234	-2%	-$104K	﹤0.01%	3584
2022 Q4	$4.43M	Buy	3,783,812 +79,425	+2%	+$100K	﹤0.01%	3781
2022 Q3	$4.19M	Sell	3,704,387 -51,370	-1%	-$75.4K	﹤0.01%	3830
2022 Q2	$5.93M	Sell	3,755,757 -6,053,366	-62%	-$7.98M	﹤0.01%	3746
2022 Q1	$15.1M	Sell	9,809,123 -199,387	-2%	-$309K	﹤0.01%	3348
2021 Q4	$24.5M	Buy	10,008,510 +1,456,810	+17%	+$3.41M	﹤0.01%	3159
2021 Q3	$21.6M	Buy	8,551,700 +12,170	+0.1%	+$31.2K	﹤0.01%	3225
2021 Q2	$24.3M	Buy	8,539,530 +6,076,041	+247%	+$15.7M	﹤0.01%	3182
2021 Q1	$5.79M	Buy	2,463,489 +862,667	+54%	+$2.07M	﹤0.01%	3872
2020 Q4	$2.82M	Buy	1,600,822 +9,957	+0.6%	+$13.9K	﹤0.01%	3923
2020 Q3	$1.49M	Sell	1,590,865 -3,712	-0.2%	-$3.28K	﹤0.01%	3984
2020 Q2	$1.39M	Sell	1,594,577 -5,732,754	-78%	-$5.05M	﹤0.01%	3947
2020 Q1	$6.07M	Buy	7,327,331 +35,350	+0.5%	+$35.2K	﹤0.01%	3265
2019 Q4	$6.49M	Buy	7,291,981 +2,439	+0%	+$2.03K	﹤0.01%	3433
2019 Q3	$7.14M	Buy	7,289,542 +198,358	+3%	+$205K	﹤0.01%	3374
2019 Q2	$7.8M	Sell	7,091,184 -127,620	-2%	-$147K	﹤0.01%	3361
2019 Q1	$9.46M	Buy	7,218,804 +1,039,523	+17%	+$1.29M	﹤0.01%	3145
2018 Q4	$5.64M	Sell	6,179,281 -795,839	-11%	-$1.22M	﹤0.01%	3356
2018 Q3	$14.3M	Buy	6,975,120 +212,456	+3%	+$446K	﹤0.01%	3047
2018 Q2	$12.2M	Buy	6,762,664 +660,653	+11%	+$1.33M	﹤0.01%	3135
2018 Q1	$14.4M	Buy	6,102,011 +48,652	+0.8%	+$114K	﹤0.01%	2941
2017 Q4	$11.4M	Buy	6,053,359 +220,644	+4%	+$482K	﹤0.01%	3083
2017 Q3	$14.5M	Buy	5,832,715 +74,823	+1%	+$186K	﹤0.01%	2968
2017 Q2	$15.9M	Buy	5,757,892 +155,708	+3%	+$435K	﹤0.01%	2906
2017 Q1	$16.9M	Buy	5,602,184 +5,596,562	+99,548%	+$15.9M	﹤0.01%	2846
2016 Q4	$18K	Sell	5,622 -676	-11%	-$2.08K	﹤0.01%	3281
2016 Q3	$21K	Buy	6,298 +1,462	+30%	+$4.04K	﹤0.01%	3272
2016 Q2	$11K	Buy	4,836 +1,008	+26%	+$2.47K	﹤0.01%	3395
2016 Q1	$10K	Buy	3,828 +2,533	+196%	+$5.65K	﹤0.01%	3159
2015 Q4	$4K	Hold	1,295	–	–	﹤0.01%	3206
2015 Q3	$3K	Hold	1,295	–	–	﹤0.01%	3118
2015 Q2	$4K	Hold	1,295	–	–	﹤0.01%	3157
2015 Q1	$5K	Buy	+1,295	New	+$4.48K	﹤0.01%	3023
2014 Q2	–	Sell	-1,658	Closed	-$4K	–	3186
2014 Q1	$4K	Hold	1,658	–	–	﹤0.01%	3085
2013 Q4	$5K	Hold	1,658	–	–	﹤0.01%	3042
2013 Q3	$5K	Hold	1,658	–	–	﹤0.01%	2991
2013 Q2	$5K	Buy	+1,658	New	+$5.31K	﹤0.01%	3030

Other funds holding LCTX

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return